2016 POSTER – DRY EYE MODEL_ARVO

The effect of a new ocular surface modulator in controlling inflammation in an in vitro model of dry eye.

Click here to read the pdf

VitroScreen Amministratore2023-12-05T12:48:46+00:00

VitroScreen s.r.l.

Testing Facility and Headquarter: via Mosè Bianchi 103 - 20149 Milano - Italy
Cap. Soc € 15.000 - P. IVA 13454040158 – REA MI n. 1653696

Contact

Ph.: 39-02-89077608
Email: Infos@vitroscreen.com | Pec: vitroscreen@pec.retesi.it

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessario Sempre attivato

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non necessario

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

2016 POSTER – DRY EYE MODEL_ARVO

Share